NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S. Callander, Muhamed Baljević, Kehinde Adekola, Larry D. Anderson, Erica Campagnaro, Jorge J. Castillo, Caitlin Costello, Srinivas Devarakonda, Noura Elsedawy, Matthew Faiman, Alfred L. Garfall, Kelly Godby, Jens Hillengaß, Leona Holmberg, Myo Htut, Carol Ann Huff, Malin Hultcrantz, Yubin Kang, Sarah Larson, Michaela Liedtke, Thomas G. Martin, James Omel, Douglas W. Sborov, Kenneth H. Shain, Keith Stockerl‐Goldstein, Donna Weber, Ryan A. Berardi, Rashmi Kumar, Shaji Kumar
Abstract
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with various plasma cell neoplasms, including multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates/changes specific to the treatment of patients with multiple myeloma in the 2022 version of the guidelines.